Roundhill Investments - GLP-1 & Weight Loss ETF OZEM NASDAQ · Financials · United States
$31.23 -1.58% -$0.50
Summary
Roundhill Investments - GLP-1 & Weight Loss ETF is an ETF - a fund traded on an exchange like a stock - run by Roundhill Investments. Positions inside: 27. The ten largest make up 69% of the fund.
- Yearly costs
- 0.59%
- Fund size
- $56.4M
- Positions
- 27
- Dividend yield
- 1.31%
- Running since
- 2024
What speaks for it
Nothing stands out in its favour.
What to watch
- The ten largest positions make up 69% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- Costs of 0.59% a year are above the middle of comparable funds (0.45%).
- A young fund: it has been running only since 2024.
- A small fund with $56.4M under management; small funds get closed more often.
- It trades little: only about $504.0K changes hands a day.
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +8.1%
- 3 months
- -6.7%
- This year
- -8.6%
- 1 year
- -1.1%
- Avg. market cap
- $271.9B
- P/E
- 19.6x
- Forward P/E
- 16.4x
- P/S
- 4.6x
- P/B
- 3.2x
- P/FCF
- 21.4x
- EV/EBITDA
- 12.4x
- Dividend yield
- 1.72%
- ROIC
- 6.9%
- ROE
- 15.2%
- Gross margin
- 50.6%
- Operating margin
- -1,926.9%
- Net margin
- -1,716.7%
- Payout ratio
- 33.6%
- Net debt/EBITDA
- 0.7x
- Beta
- 0.47
Weighted average of the 24 largest companies, which make up 100% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 LLEli Lilly LLY 15%
- 2 NVNovo Nordisk NVO 12%
- 3 PFPfizer PFE 7.9%
- 4 KLKailera Therapeutics, Inc. KLRA 5.9%
- 5 10CSPC Pharmaceutical Group Limited 1093.HK 5.5%
- 6 45Chugai Pharmaceutical Co., Ltd. 4519.T 5.0%
- 7 AMAmgen AMGN 4.8%
- 8 VKViking Therapeutics VKTX 4.5%
- 9 AZAstraZeneca AZN 4.4%
- 10 12Hanmi Pharm. Co., Ltd. 128940.KS 4.0%
Positions in the fund: 27. The ten largest make up 69% of it.
Composition as of Nov 7, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 46%
- Denmark 18%
- China 13%
- Japan 6.6%
- Other countries 17%
By company size
- Mega cap 30%
- Large cap 40%
- Mid cap 15%
- Small cap 15%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (100%). Largest country: United States (46%). Largest size group: Large cap (40%).
What does it cost me?
Expensive- A year from $10,000
- $59.00
- Over 20 years
- $2,828
From every $10,000 invested the fund takes $59.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,828.
How has it done?
Losing value- Over the last year
- -1.1%
- Deepest drop
- -29%
- Yearly volatility
- 23%
Decline over the last year: 1.1%. Deepest drop in these years: 29% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 1.31%
- Last payment
- $0.41
Over the last 12 months it paid $0.41 per share, which is 1.31% of today's price. The last payment was $0.41 on Dec 30, 2025.
Is it easy to buy and sell?
It trades little- Traded a day
- $504.0K
- Shares a day
- 16K
On an average day about $504.0K of the fund changes hands.
How expensive are the companies inside?
Usual valuation- P/E of the companies inside
- 19.6
- Average Bulios Score
- 64 out of 100
Weight by Bulios Fair Price
- Undervalued 51%
- Fairly valued 16%
- Overvalued 33%
On average the companies inside trade for 19.6 times their yearly profit. By Fair Price, 51% of the rated weight comes out as undervalued.
Counted from its largest companies (24), which make up 100% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
TH THNR Amplify ETF Trust | United States | 0.59% | $5.17M | +4.5% | Pays out | 68% |
PE PEPT REX Peptide ETF | United States | 0.65% | $1.35M | - | - | 32% |
PP PPH VanEck Pharmaceutical ETF | United States | 0.36% | $1.07B | +22% | Pays out | 29% |
ME MEDX Horizon Kinetics Medical ETF | United States | 0.85% | $17.7M | +16% | Pays out | 27% |
LI LIFE.TO Evolve Global Healthcare Enhanced Yield Fund | Canada | 0.45% | $265.0M | -3.3% | Pays out | 27% |
ZP ZPDH.DE State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) | Ireland | 0.15% | $648.2M | +31% | Reinvests | 23% |
